Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current Insights and Future Directions DOI
Yingying Gu,

Xinru Zhao,

Nan Zhang

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: 102, P. 102577 - 102577

Published: Nov. 10, 2024

Language: Английский

Wastewater-borne markers of neurodegenerative disease: β-methylamino-L-alanine and aminomethylphosphonic acid DOI
Melanie Engstrom Newell,

Ayesha Babbrah,

Anumitha Aravindan

et al.

The Science of The Total Environment, Journal Year: 2025, Volume and Issue: 970, P. 179032 - 179032

Published: March 1, 2025

Language: Английский

Citations

0

Aging, vascular dysfunction, and the blood–brain barrier: unveiling the pathophysiology of stroke in older adults DOI
Saleh I. Alaqel, Mohd Imran,

Abida Khan

et al.

Biogerontology, Journal Year: 2025, Volume and Issue: 26(2)

Published: March 5, 2025

Language: Английский

Citations

0

Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders DOI Open Access
Bai Lu,

Leijie Yu,

Mao‐Sheng Ran

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2491 - 2491

Published: March 11, 2025

Exosomes, which are nano-sized natural vesicles secreted by cells, crucial for intercellular communication and interactions, playing a significant role in various physiological pathological processes. Their characteristics, such as low toxicity immunogenicity, high biocompatibility, remarkable drug delivery capabilities—particularly their capacity to traverse the blood–brain barrier—make exosomes highly promising vehicles administration treatment of brain disorders. This review provides comprehensive overview exosome biogenesis isolation techniques, strategies loading functionalization exosomes, exosome-mediated barrier penetration mechanisms, with particular emphasis on recent advances exosome-based Finally, we address opportunities challenges associated utilizing system brain, summarizing barriers clinical translation proposing future research directions.

Language: Английский

Citations

0

Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions DOI Creative Commons

Sam Dehghani,

Ozgecan Ocakcı,

Pars Tan Hatipoglu

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: March 17, 2025

Abstract Neurodegenerative diseases (NDs) like Alzheimer’s, Parkinson’s, and ALS rank among the most challenging global health issues, marked by substantial obstacles in early diagnosis effective treatment. Current diagnostic techniques frequently demonstrate inadequate sensitivity specificity, whilst conventional treatment strategies encounter challenges related to restricted bioavailability insufficient blood–brain barrier (BBB) permeability. Recently, exosomes—nanoscale vesicles packed with proteins, RNAs, lipids—have emerged as promising agents potential reshape therapeutic approaches these diseases. Unlike drug carriers, they naturally traverse BBB can deliver bioactive molecules affected neural cells. Their molecular cargo influence cell signaling, reduce neuroinflammation, potentially slow neurodegenerative progression. Moreover, exosomes serve non-invasive biomarkers, enabling precise while allowing real-time disease monitoring. Additionally, engineered exosomes, loaded molecules, enhance this capability targeting diseased neurons overcoming barriers. By offering enhanced reduced immunogenicity, an ability bypass physiological limitations, exosome-based present a transformative advantage over existing approaches. This review examines multifaceted role of NDDs, emphasizing their capabilities, intrinsic functions, advanced vehicles.

Language: Английский

Citations

0

The Janus Face of Oxidative Stress and Hydrogen Sulfide: Insights into Neurodegenerative Disease Pathogenesis DOI Creative Commons
Constantin Munteanu, Anca‐Irina Galaction, Gelu Onose

et al.

Antioxidants, Journal Year: 2025, Volume and Issue: 14(3), P. 360 - 360

Published: March 19, 2025

Oxidative stress plays an essential role in neurodegenerative pathophysiology, acting as both a critical signaling mediator and driver of neuronal damage. Hydrogen sulfide (H2S), versatile gasotransmitter, exhibits similarly “Janus-faced” nature, potent antioxidant cytoprotective molecule at physiological concentrations, but becoming detrimental when dysregulated. This review explores the dual roles oxidative H2S normal cellular physiology focusing on disease progression. We highlight potential therapeutic opportunities for targeting redox sulfur-based systems diseases by elucidating intricate balance between these opposing forces.

Language: Английский

Citations

0

Natural products in neurodegenerative diseases: recent advances and future outlook DOI Creative Commons

Lutfun Nahar,

Rawiwan Charoensup,

Kulyash Kalieva

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: March 19, 2025

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s are on the rise pose significant challenges due to lack of effective treatments. This review critically examines neuroprotective effects various natural products derived from plants, marine organisms, fungi. Natural have long been used in traditional medicine gaining attention modern drug discovery for their unique properties. The explains how these can protect neurons by influencing key biological pathways involved neurodegeneration. It discusses mechanisms including antioxidant effects, anti-inflammatory actions, modulation cellular signalling, support mitochondrial function. A systematic literature search was conducted minimize bias ensure rigorous study selection. Preclinical studies using animal models cell cultures show that secondary metabolites like polyphenols, alkaloids, terpenoids significantly reduce neuronal damage. Some clinical trials shown promising results. However, bioavailability, standardization, dosage must be addressed translate findings into practice. also evaluates potential synergy combining with conventional treatments, offering a complementary therapeutic approach. represent avenue developing innovative treatments neurodegenerative diseases. highlights research gaps proposes future directions. Future should focus overcoming existing refining improve efficacy safety settings. application knowledge has enhance quality life individuals affected

Language: Английский

Citations

0

Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer’s and Parkinson’s disease DOI Creative Commons

Faye T.C. Lau,

Rebecca Binacchi,

S. Brugnara

et al.

Neuroscience, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Role of Electrospun Conductive Polymeric Nanofibers for Inducing Neuronal Tissue Regeneration—A Novel Strategy for Targeting Neurodegenerative Disorders DOI
Priya Palanisamy,

Weslen Vedakumari Sathyaraj,

Yovan Raja Pravin

et al.

Regenerative Engineering and Translational Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0

Nanomaterial-based approaches to neurotoxin neutralization in neurodegenerative diseases DOI
Meng Cheng, Yan Dou

Nanomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 13

Published: April 3, 2025

Neurodegenerative diseases (NDs) are intricately linked to the accumulation of various neurotoxins, mainly including toxic proteins, inflammatory mediators, excess metal ions, and viral pathogens. Biological neutralization strategies that use agents competitively bind harmful substances thus inhibit their pathogenic activity hold promise for direct removal neurotoxins but face many limitations challenges in NDs. Nanomaterials provide a potential solution neurotoxin NDs due unique physicochemical biological properties. This review summarizes recent advancements nanomaterial-based approaches NDs, highlighting diverse design principles mechanisms action. We also discuss critical role targeted delivery optimize efficiency advantages combining different or introducing other therapeutic components exert synergistic effects. Furthermore, we reveal current future research directions aimed at paving way nanomedicine development based on treatment

Language: Английский

Citations

0

Combining dopamine and vitamin E enhances the differentiation to cholinergic neurons of mesenchymal stem cells DOI Creative Commons

Ramada R Khaswaneh,

Ejlal Abu‐El‐Rub,

Ayman Alzu’bi

et al.

Journal of Neuropathology & Experimental Neurology, Journal Year: 2025, Volume and Issue: unknown

Published: March 12, 2025

Recent research indicates that mesenchymal stem cells (MSCs) can transdifferentiate into neuron-like under specific conditions, offering promise for neuronal regeneration. However, challenges remain in optimizing differentiation protocols to generate neuron types. This study explores the impact of supplementing induction media with dopamine and vitamin E guide MSCs toward subtypes. Human adipose-MSCs were utilized investigate differentiation. The cultured supplemented 2 concentrations (2.5 5 µM) (12.5 25 µM). Immunostaining western blot analysis employed assess sequential expression markers associated various stages maturation development. These included Nestin, MAP2, NeuN, TBR1, SATB2, DAT, DBH, CHAT. results demonstrate, first time, significantly enhances accelerates cells. Furthermore, findings suggest induced are predominantly reprogrammed a cholinergic lineage. For MSCs, our reveals addition reprograms mainly neurons, suggesting promising approaches treating neurodegenerative disorders.

Language: Английский

Citations

0